High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers.

Yeh, K H; Lin, M T; Lin, D T; Tang, J L; Lui, L T; Lin, J F; Chang, Y S; Cheng, A L; Yu, S C; Chang, K J; Chen, Y C

Yeh, K H; Lin, M T; Lin, D T; Tang, J L; Lui, L T; Lin, J F; Chang, Y S; Cheng, A L; Yu, S C; Chang, K J; Chen, Y C.

Affiliation

Yeh KH; Department of Oncology, National Taiwan University Hospital, Cancer Research Center and Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei.

Breast Cancer Res Treat ; 49(3): 237-44, 1998 Jun.

Article in En | MEDLINE | ID: mdl-9776507

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Breast Neoplasms/therapy; Granulocyte Colony-Stimulating Factor/therapeutic use; Adult; Breast Neoplasms/mortality; Clinical Protocols; Cyclophosphamide/administration & dosage; Epirubicin/administration & dosage; Female; Fluorouracil/administration & dosage; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Middle Aged; Radiotherapy, Adjuvant; Recurrence; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Breast Cancer Res Treat Year: 1998 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links